Mild cognitive impairment and its management in older people

Sima Ataollahi Eshkoor1, Tengku Aizan Hamid1, Chan Yoke Mun1

  • 1Institute of Gerontology, Universiti Putra Malaysia, Selangor, Malaysia.

Insights

Protecting older adults against mild cognitive impairment (MCI) and dementia is crucial. Preventive strategies include lifestyle changes, exercise, and managing health conditions to maintain cognitive function.

Area of Science:

  • Gerontology
  • Neurology
  • Public Health

Background:

  • Mild cognitive impairment (MCI) affects the elderly, causing memory and cognitive decline beyond normal aging.
  • MCI can be a precursor to dementia, with 10-15% converting annually.
  • The growing elderly population worldwide increases MCI prevalence.

Purpose of the Study:

  • To highlight the importance of preventing MCI and dementia in older adults.
  • To identify protective interventions and treatments for cognitive decline.
  • To emphasize the need for further research into MCI causes and progression.

Main Methods:

  • Review of existing literature on MCI prevention and treatment.
  • Identification of risk factors and protective strategies.
  • Analysis of the impact of lifestyle, diet, and medical conditions on cognitive health.

Main Results:

  • Preventive measures include avoiding toxins, reducing stress, and managing diseases.
  • Mental and physical exercises, antioxidants, and supplements show protective potential.
  • Modifying risk factors like smoking and correcting vitamin/hormone deficiencies are key.

Conclusions:

  • Comprehensive strategies are needed to protect against MCI and dementia.
  • Lifestyle modifications and early interventions are vital for cognitive health in the elderly.
  • Further research is essential to understand MCI progression and develop effective treatments.

Related Concept Videos

Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
1.3K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
901
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
728
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
368